Navigation Links
Mast Therapeutics Reports Third Quarter 2013 Financial Results
Date:11/4/2013

SAN DIEGO, Nov. 4, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported financial results for the quarter ended September 30, 2013.

Brian M. Culley, Chief Executive Officer, said: "We continue to focus on EPIC, our pivotal phase 3 study of MST-188 in sickle cell disease.  We almost doubled the number of open clinical sites since the end of the second quarter and are approaching our goal of opening 40 clinical sites in the U.S. Beginning next year, we also plan to open approximately 30 clinical sites outside the U.S."

Mr. Culley continued: "In addition to sickle cell disease, we are evaluating MST-188 in other areas of significant unmet medical need and plan to initiate a 60-patient phase 2 study in acute limb ischemia in early 2014.  This study will determine whether MST-188 improves the effectiveness of existing thrombolytic agents, such as Activase®, a tissue plasminogen activator (tPA) that is approved to treat stroke, heart attack and pulmonary embolism.  If our phase 2 study demonstrates that MST-188 improves the 'clot busting' activity of tPA, we believe it will open the door to developing MST-188 in combination with tPA in all settings in which thrombolytics are used, most notably stroke." 

Third Quarter 2013 Operating ResultsThe Company's net loss for the third quarter of 2013 was $5.3 million, or $0.05 per share (basic and diluted), compared to a net loss of $3.2 million, or $0.07 per share (basic and diluted), for the same period in 2012.

Research and development (R&D) expenses for the third quarter of 2013 were $3.1 million, an increase of $1.4 million, or 87%, compared to $1.7 million for the same period in 2012. The increase was primarily due to increases of $1.3 million in external clinical study fees and expenses and $
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients
2. Echo Therapeutics Schedules Third Quarter 2013 Financial Results for Thursday, November 7, 2013
3. G1 Therapeutics to Present at Southeast BIO Investor & Partnering Forum
4. Cell Therapeutics Reports Third Quarter 2013 Financial Results
5. Sorrento Therapeutics Announces Closing of Public Offering of Common Stock
6. Abide Therapeutics Appoints Dr. Gary ONeill as Vice President of Biology
7. Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013
8. Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure
9. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
10. ISSYS Inc. will showcase its Titan Wireless Implantable Hemodynamic Monitor and its clinical study summary at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference (Booth 1638) in San Francisco (October 29 to 31, 2013)
11. Aratana Therapeutics Adds to Commercial Leadership Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... has been appointed President and Chief Executive Officer, effective ... has stepped down from his executive and Board roles ... through the first quarter of 2016.  ...
(Date:9/22/2014)... 22, 2014 Research and Markets  has ... Diclofenac Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The diclofenac ...
(Date:9/22/2014)... SHENZHEN, China , Sept. 22, 2014 China Nepstar ... "Company"), a leading retail drugstore chain in China ... that it will hold its 2014 Annual General Meeting of Shareholders ... The AGM will be held at the meeting room of the ... District, Shenzhen , Guangdong Province ...
Breaking Medicine Technology:Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5Global and Chinese Diclofenac Industry Report 2014 2China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2
... 3, 2010 The American College of Radiology (ACR) distributed ... ( MCR5 ) educational CD-ROM free of charge to physicians ... Mammography Case Review ( MCR5 ... improve their skills regarding the detection of cancers and other ...
... contract research organization will expand its operations in Chester County ... the Department of Community and Economic Development announced today. ... in Wayne, purchase new equipment and provide employee training. The ... three years and retain 80 existing positions.   ...
Cached Medicine Technology:ACR Distributes Free High-Tech Mammography Education Tool to NY Facilities 2Research Facility Expansion Will Create, Retain More than 150 Jobs in Chester County 2
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- Teens and young adults ... behavioral counseling to help prevent risky sexual behaviors, according ... Force. Every year, about 20 million new sexually ... the United States. About half involve people between 15 ... Its new report, published Sept. 22 in ...
(Date:9/22/2014)... study pulls back the curtain on one of the ... and income between physicians who perform operations, procedures or ... perception, the research indicates, the physician payment system is ... doctors. , The new findings counter the widely held ... explains why doctors who perform procedures often earn nearly ...
(Date:9/22/2014)... September 22, 2014 Manhattan residents who ... side of the hip , which could be bursitis ... This treatment is now offered at New York Dynamic ... called trochanteric bursitis, occurs when the trochanteric bursa becomes ... in the hip, between the iliotibial band and the ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, 2014 ... 6 months and older be vaccinated for the upcoming flu ... vaccine recommendations to advise that the youngest kids should have ... also wants parents of children aged 2 to 8 to ... the flu shot if it,s readily available. "It,s important ...
(Date:9/22/2014)... MA Up to 40 percent of patients undergoing ... fail to remove all the cancerous tissue in the ... (BWH) have successfully tested a tool they developed that ... normal tissue, thereby decreasing the chances for repeat operations. ... the week of September 22, 2014 in the ...
Breaking Medicine News(10 mins):Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:The fine line between breast cancer and normal tissues 2
... States,Agency for International Development (USAID) is pleased to ... reduces the risk of,diarrhea. Sur,Eau is a water ... can be added to water immediately before,use and ... children and,people living with HIV and AIDS -- ...
... SAN DIEGO, April 25 SynergEyes, Inc., of ... designed for people,who need further vision correction after ... designed for patients who,have experienced some type of ... Every year, millions of people undergo LASIK ...
... Nonprofit Health Systems Research Institute as New Vice ... ... leader,and advocate on HIV/AIDS issues, has joined the nonprofit Altarum Institute,as Vice ... began the search for someone to lead our Community Health,Systems Group, I ...
... Comments Made by TV Game Show Host Spark Controversy, ... long-time host of,the television game show "The Price Is ... (CDOC), a non-profit group formed to,support responsible dog ownership. ... neuter law that went into effect this month in ...
... North Carolina-based Oaks,Development Group announced today ... Olympia Avenue, in Punta Gorda, Florida. The,29,927-square-foot ... near,Charlotte Regional Medical Center and currently includes ... converted to Oaks, unique,tenant-ownership model., Oaks, ...
... Tanzania, April 25 Today is a,great day for the ... a day to,celebrate. We celebrate because of the possibilities that ... by the United,Nations Secretary General His Excellency Ban Ki-Moon, presents ... is implemented to the,letter, millions of lives will be saved ...
Cached Medicine News:Health News:Disinfecting Water Saves Lives in Rwanda 2Health News:SynergEyes Hybrid Contact Lenses Provide a Vision Solution for Post-LASIK Patients 2Health News:Prominent Advocate on HIV/AIDS Issues Joins Altarum Institute 2Health News:Bob Barker's 'Right' to Free Speech Comes with a 'Price' 2Health News:Oaks Development Group Acquires Medical Office Building in Punta Gorda, Florida 2Health News:Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: